"Designing Growth Strategies is in our DNA"

Ophthalmic Disease Therapeutics Market Size, Share and Industry Analysis By Disease Indication (Glaucoma, Retinal Diseases, Dry Eye Disease, Allergy & Infections), By Drug Class (Anti-inflammatory, Anti-infectives, Anti-VEGF, Anti-glaucoma), By Dosage Form (Solid, Liquid, Semi-solid), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Regional Forecast 2019-2026

Region : Global | Format: PDF | Report ID: FBI100441

 

Table of Content:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions andAssumptions

2. Executive Summary

3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1 Recent Industry Developments Such as Partnerships, Mergers & Acquisitions

4.2 Prevalence of Major Ophthalmic Diseases, in Key Countries, 2018

4.3 Pipeline Analysis

4.4 Patent Landscape

4.5 Reimbursement Scenario by Key Countries

4.6 Regulatory scenario for key countries

5. Global Ophthalmic Disease Therapeutics Market Analysis, Insights and Forecast, 2015-2026

5.1. Key Findings / Summary

5.2. Market Analysis,Insights and Forecast – By Disease Indication

5.2.1 Glaucoma

5.2.1.1 Open Angle Glaucoma

5.2.1.2 Angle Closure Glaucoma

5.2.1.3 Others

5.2.2 Retinal Diseases

5.2.2.1 Diabetic Macular Edema

5.2.2.2 Macular Degeneration

5.2.2.3 Diabetic Retinopathy

5.2.2.4 Retinal Vein Occlusion

5.2.2.5 Others

5.2.3 Dry Eye Disease

5.2.4 Allergy & Infections

5.2.5 Others

5.3. Market Analysis,Insights and Forecast – By Dosage Form

5.3.1 Solid

5.3.2 Liquid

5.3.3 Semi-solid

5.4 Market Analysis,Insights and Forecast – By Drug Class

5.4.1 Anti-inflammatory

5.4.2 Anti-infectives

5.4.3 Anti-VEGF

5.4.4 Anti-glaucoma

5.5. Market Analysis,Insights and Forecast – By End User

5.5.1 Hospital Pharmacy

5.5.2 Retail Pharmacy

5.5.3 Online Pharmacy

5.6. Market Analysis,Insights and Forecast – By Region

5.6.1 North America

5.6.2 Europe

5.6.3 Asia Pacific

5.6.4 Latin America

5.6.5 Middle East & Africa

6. North America Ophthalmic Disease Therapeutics Market Analysis,Insights and Forecast, 2015-2026

6.1. Key Findings / Summary

6.2. Market Analysis – By Disease Indication

6.2.1 Glaucoma

6.2.1.1 Open Angle Glaucoma

6.2.1.2 Angle Closure Glaucoma

6.2.1.3 Others

6.2.2 Retinal Diseases

6.2.2.1 Diabetic Macular Edema

6.2.2.2 Macular Degeneration

6.2.2.3 Diabetic Retinopathy

6.2.2.4 Retinal Vein Occlusion

6.2.2.5 Others

6.2.3 Dry Eye Disease

6.2.4 Allergy & Infections

6.2.5 Others

6.3. Market Analysis – By Dosage Form

6.3.1 Solid

6.3.2 Liquid

6.3.3 Semi-solid

6.4. Market Analysis – By Drug Class

6.4.1 Anti-inflammatory

6.4.2 Anti-infectives

6.4.3 Anti-VEGF

6.4.4 Anti-glaucoma

6.5. Market Analysis – By End User

6.5.1 Hospital Pharmacy

6.5.2 Retail Pharmacy

6.5.3 Online Pharmacy

6.6. Market Analysis – By Country

6.6.1 U.S

6.6.2 Canada

7. Europe Ophthalmic Disease Therapeutics Market Analysis, Insights and Forecast, 2015-2026

7.1. Key Findings / Summary

7.2. Market Analysis – By Disease Indication

7.2.1 Glaucoma

7.2.1.1 Open Angle Glaucoma

7.2.1.2 Angle Closure Glaucoma

7.2.1.3 Others

7.2.2 Retinal Diseases

7.2.2.1 Diabetic Macular Edema

7.2.2.2 Macular Degeneration

7.2.2.3 Diabetic Retinopathy

7.2.2.4 Retinal Vein Occlusion

7.2.2.5 Others

7.2.3 Dry Eye Disease

7.2.4 Allergy & Infections

7.2.5 Others

7.3. Market Analysis – By Dosage Form

7.3.1 Solid

7.3.2 Liquid

7.3.3 Semi-solid

7.4. Market Analysis – By Drug Class

7.4.1 Anti-inflammatory

7.4.2 Anti-infectives

7.4.3 Anti-VEGF

7.4.4 Anti-glaucoma

7.5. Market Analysis – By End User

7.5.1 Hospital Pharmacy

7.5.2 Retail Pharmacy

7.5.3 Online Pharmacy

7.6. Market Analysis – By Country/Sub-region

7.6.1 Germany

7.6.2 U.K

7.6.3 France

7.6.4 Itlay

7.6.5 Spain

7.6.6 Scandinavia

7.6.7 Rest of Europe

8. Asia Pacific Ophthalmic Disease Therapeutics Market Analysis, Insights and Forecast, 2015-2026

8.1. Key Findings / Summary

8.2. Market Analysis – By Disease Indication

8.2.1 Glaucoma

8.2.1.1 Open Angle Glaucoma

8.2.1.2 Angle Closure Glaucoma

8.2.1.3 Others

8.2.2 Retinal Diseases

8.2.2.1 Diabetic Macular Edema

8.2.2.2 Macular Degeneration

8.2.2.3 Diabetic Retinopathy

8.2.2.4 Retinal Vein Occlusion

8.2.2.5 Others

8.2.3 Dry Eye Disease

8.2.4 Allergy & Infections

8.2.5 Others

8.3. Market Analysis – By Dosage Form

8.3.1 Solid

8.3.2 Liquid

8.3.3 Semi-solid

8.4. Market Analysis – By Drug Class

8.4.1 Anti-inflammatory

8.4.2 Anti-infectives

8.4.3 Anti-VEGF

8.4.4 Anti-glaucoma

8.5. Market Analysis – By End User

8.5.1 Hospital Pharmacy

8.5.2 Retail Pharmacy

8.5.3 Online Pharmacy

8.6. Market Analysis – By Country/Sub-region

8.6.1 India

8.6.2 China

8.6.3 Japan

8.6.4 Australia

8.6.5 Southeast Asia

8.6.6 Rest of Asia Pacific

9. Latin America Ophthalmic Disease Therapeutics Market Analysis, Insights and Forecast, 2015-2026

9.1. Key Findings / Summary

9.2. Market Analysis – By Disease Indication

9.2.1 Glaucoma

9.2.1.1 Open Angle Glaucoma

9.2.1.2 Angle Closure Glaucoma

9.2.1.3 Others

9.2.2 Retinal Diseases

9.2.2.1 Diabetic Macular Edema

9.2.2.2 Macular Degeneration

9.2.2.3 Diabetic Retinopathy

9.2.2.4 Retinal Vein Occlusion

9.2.2.5 Others

9.2.3 Dry Eye Disease

9.2.4 Allergy & Infections

9.2.5 Others

9.3. Market Analysis – By Dosage Form

9.3.1 Solid

9.3.2 Liquid

9.3.3 Semi-solid

9.4. Market Analysis – By Drug Class

9.4.1 Anti-inflammatory

9.4.2 Anti-infectives

9.4.3 Anti-VEGF

9.4.4 Anti-glaucoma

9.5. Market Analysis – By End User

9.5.1 Hospital Pharmacy

9.5.2 Retail Pharmacy

9.5.3 Online Pharmacy

9.6. Market Analysis – By Country/Sub-region

9.6.1 Brazil

9.6.2 Mexico

9.6.3 Rest of Latin America

10. Middle East & Africa Ophthalmic Disease Therapeutics Market Analysis, Insights and Forecast, 2015-2026

10.1. Key Findings / Summary

10.2. Market Analysis – By Disease Indication

10.2.1 Glaucoma

10.2.1.1 Open Angle Glaucoma

10.2.1.2 Angle Closure Glaucoma

10.2.1.3 Others

10.2.2 Retinal Diseases

10.2.2.1 Diabetic Macular Edema

10.2.2.2 Macular Degeneration

10.2.2.3 Diabetic Retinopathy

10.2.2.4 Retinal Vein Occlusion

10.2.2.5 Others

10.2.3 Dry Eye Disease

10.2.4 Allergy & Infections

10.2.5 Others

10.3. Market Analysis – By Dosage Form

10.3.1 Solid

10.3.2 Liquid

10.3.3 Semi-solid

10.4. Market Analysis – By Drug Class

10.4.1 Anti-inflammatory

10.4.2 Anti-infectives

10.4.3 Anti-VEGF

10.4.4 Anti-glaucoma

10.5. Market Analysis – By End User

10.5.1 Hospital Pharmacy

10.5.2 Retail Pharmacy

10.5.3 Online Pharmacy

10.6. Market Analysis – By Country/Sub-region

10.6.1 GCC

10.6.2 South Africa

10.6.3 Rest of Middle East & Africa

11. Competitive Analysis

11.1. Key Industry Developments

11.2. Global Market Share Analysis (2018)

11.3. Competition Dashboard

11.4. Comparative Analysis –Major Players

11.5. Company Profiles(Overview, Products & services, SWOT analysis, Recent developments,strategies, financials (based on availability))

11.5.1 Merck & Co., Inc.

11.5.2 Pfizer, Inc.

11.5.3 Novartis AG

11.5.4 Allergan plc

11.5.5 F.Hoffmann-La Roche AG

11.5.6 Regeneron Pharmaceuticals, Inc.

11.5.7 Santen Pharmaceutical Co., Ltd.

11.5.8 Bayer AG

11.5.9 Bausch & Lomb, Inc.

12. Strategic Recommendations

 class=
  • Jun, 2019
  • 2018
  • 2015-2017
  • 156

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X